CD4 and neoplasm: The results showed the depletion of CD8+ cytotoxic T cells, CD4+ T cells and NK cells significantly decreased the therapeutic efficacy of Nano‐IL‐12, as indicated by the faster tumor growth and the decreased survival in the depleted groups compared to the mice receiving only the Nano‐IL‐12 treatment (Figure 4b).